412 related articles for article (PubMed ID: 36430704)
1. Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing.
Gisina A; Kholodenko I; Kim Y; Abakumov M; Lupatov A; Yarygin K
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430704
[TBL] [Abstract][Full Text] [Related]
2. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
3. Distinct metabolic hallmarks of WHO classified adult glioma subtypes.
Björkblom B; Wibom C; Eriksson M; Bergenheim AT; Sjöberg RL; Jonsson P; Brännström T; Antti H; Sandström M; Melin B
Neuro Oncol; 2022 Sep; 24(9):1454-1468. PubMed ID: 35157758
[TBL] [Abstract][Full Text] [Related]
4. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
Santosh V; Rao S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
[TBL] [Abstract][Full Text] [Related]
5. A tiger behind many doors: multiple genetic pathways to malignant glioma.
Louis DN; Gusella JF
Trends Genet; 1995 Oct; 11(10):412-5. PubMed ID: 7482768
[TBL] [Abstract][Full Text] [Related]
6. Glioma models.
Dai C; Holland EC
Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
[TBL] [Abstract][Full Text] [Related]
7. [Occurrence and molecular pathology of high grade gliomas].
Murnyák B; Csonka T; Hegyi K; Méhes G; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):312-21. PubMed ID: 24358686
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
[TBL] [Abstract][Full Text] [Related]
9. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
[TBL] [Abstract][Full Text] [Related]
11. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
12. BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel R; Ulloa-Navas MJ; García-Tárraga P; Prat-Acín R; Reynés G; Pérez-Borredá P; Rubio L; Capilla-González V; Ferrer-Lozano J; García-Verdugo JM
Oncotarget; 2024 Jan; 15():49-64. PubMed ID: 38275289
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
[TBL] [Abstract][Full Text] [Related]
14. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
15. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
16. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas.
Li JY; Wang H; May S; Song X; Fueyo J; Fuller GN; Wang H
J Neurooncol; 2008 May; 88(1):11-7. PubMed ID: 18246408
[TBL] [Abstract][Full Text] [Related]
19. Spatial concordance of DNA methylation classification in diffuse glioma.
Verburg N; Barthel FP; Anderson KJ; Johnson KC; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Rozemuller AJM; Beliën JAM; Boellaard R; Taylor MD; Das S; Costello JF; Vandertop WP; Wesseling P; de Witt Hamer PC; Verhaak RGW
Neuro Oncol; 2021 Dec; 23(12):2054-2065. PubMed ID: 34049406
[TBL] [Abstract][Full Text] [Related]
20. Dissecting human gliomas by single-cell RNA sequencing.
Tirosh I; Suvà ML
Neuro Oncol; 2018 Jan; 20(1):37-43. PubMed ID: 29016805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]